Patents by Inventor Tiziana Monti

Tiziana Monti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7619099
    Abstract: An improved process for the production of maleic anhydride by the catalytic oxidation of n-butane. Maleic anhydride is produced by reacting n-butane gas with oxygen gas or an oxygen-containing gas, in the presence of a vanadium phosphorus oxide catalyst. A trialkyl phosphite or trialkyl phosphate component is continuously added to the gases in an amount of from about 0.5 ppm to about 4 ppm by weight of elemental phosphorus in the trialkyl phosphate or trialkyl phosphite component. Heat is applied to the gases at a temperature of from about 400° C. to about 440° C. while maintaining a maximum temperature of gases present in the reaction of about 480° C. A simultaneous conversion of n-butane to maleic anhydride of about 84% or more and a conversion of n-butane to by-product acrylic acid of about 1.5% or less is achieved.
    Type: Grant
    Filed: April 17, 2006
    Date of Patent: November 17, 2009
    Assignees: Scientific Design Company, Inc., Lonza S.p.A.
    Inventors: Ashok S. Padia, Arie Bortinger, Gianluca Mazzoni, Tiziana Monti
  • Publication number: 20070244332
    Abstract: An improved process for the production of maleic anhydride by the catalytic oxidation of n-butane. Maleic anhydride is produced by reacting n-butane gas with oxygen gas or an oxygen-containing gas, in the presence of a vanadium phosphorus oxide catalyst. A trialkyl phosphite or trialkyl phosphate component is continuously added to the gases in an amount of from about 0.5 ppm to about 4 ppm by weight of elemental phosphorus in the trialkyl phosphate or trialkyl phosphite component. Heat is applied to the gases at a temperature of from about 400° C. to about 440° C. while maintaining a maximum temperature of gases present in the reaction of about 480° C. A simultaneous conversion of n-butane to maleic anhydride of about 84% or more and a conversion of n-butane to by-product acrylic acid of about 1.5% or less is achieved.
    Type: Application
    Filed: April 17, 2006
    Publication date: October 18, 2007
    Inventors: Ashok Padia, Arie Bortinger, Gianluca Mazzoni, Tiziana Monti
  • Patent number: 7186755
    Abstract: The present invention relates to nimesulide topical formulations comprising a carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and a solvent selected from the group consisting of ethanol, isopropanol and diethylene glycol monoethyl ether, and to the process for the preparation thereof. Said formulations have advantages such as higher stability of the system and bioavailability of the active ingredient.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: March 6, 2007
    Assignee: Helsinn Health Care S.A.
    Inventors: Stefano Bader, Enrique Häusermann, Tiziana Monti
  • Patent number: 6858561
    Abstract: A process for preparing a catalyst for maleic anhydride production wherein a +5 vanadium compound such as V2O5, an anhydrous phosphoric acid, and optionally promoters are admixed in an organic alcohol solvent, the admixture is rapidly brought to reflux and thereafter refluxed to reduced the vanadium compound to the desired degree, the reflux mixture is cooled, precursor crystals are separated by filtration and then dried and calcined.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: February 22, 2005
    Assignees: Scientific Design Company, Inc., Lonza S.p.A.
    Inventors: Arie Bortinger, Gianluca Mazzoni, Tiziana Monti
  • Publication number: 20030036563
    Abstract: The present invention relates to nimesulide topical formulations comprising a carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and a solvent selected from the group consisting of ethanol, isopropanol and diethylene glycol monoethyl ether, and to the process for the preparation thereof. Said formulations have advantages such as higher stability of the system and bioavailability of the active ingredient.
    Type: Application
    Filed: September 26, 2002
    Publication date: February 20, 2003
    Applicant: HELSINN HEALTHCARE S.A.
    Inventors: Stefano Bader, Enrique Hausermann, Tiziana Monti
  • Publication number: 20020119997
    Abstract: The present invention relates to nimesulide topical formulations comprising a carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and a solvent selected from the group consisting of ethanol, isopropanol and diethylene glycol monoethyl ether, and to the process for the preparation thereof Said formulations have advantages such as higher stability of the system and bioavailability of the active ingredient.
    Type: Application
    Filed: October 7, 1999
    Publication date: August 29, 2002
    Inventors: STEFANO BADER, ENRIQUE HAUSERMANN, TIZIANA MONTI
  • Patent number: 6288121
    Abstract: Nimesulide topical formulations are provided in the form of liquid crystals. The emulsifier cetylstearyl glycoside is used, and constituents of the lipid phase such as caprylic/capric triglycerides and jojoba oil, consistence factors such as cetylstearyl alcohol. Also disclosed is a process for the preparation thereof. The formulations have advantages such as higher stability, better release and absorption of nimesulide, and a higher bioavailability of the active ingredient.
    Type: Grant
    Filed: August 4, 1999
    Date of Patent: September 11, 2001
    Assignee: Helsinn Healthcare S.A.
    Inventors: Stefano Bader, Enrique Hausermann, Tiziana Monti